Siemens at SNMMI 2014Society of Nuclear Medicine and Molecular Imaging Annual Meeting

See How Siemens Innovations are Changing the Future of Molecular Imaging!

Join Siemens at the SNMMI annual meeting and experience how the future of molecular imaging is changing! See how Siemens innovations are playing a unique role in breaking through the limitations of traditional molecular imaging. We delivered the technology. Now witness the evidence of innovation. Come by and experience Siemens’ Symbia Intevo xSPECT system, which integrates both SPECT and CT data during reconstruction to derive high resolution images that are now fully quantitative. Powered by Siemens’ revolutionary FlowMotion™ technology, Biograph mCT Flow™ is the world’s first PET•CT system to eliminate the demand for stop-and-go imaging. Now with Biograph mCT Flow and FlowMotion, planning and scanning is based on a single continuous motion of the patient table. Experience these cutting-edge technologies and find the answers to your most challenging questions. Siemens delivers to help find disease early, confidently characterize it and follow treatment accurately.

Symbia Intevo

Symbia Intevo™1 the world’s first xSPECT1 system, provides physicians with the potential to not only image disease, but also leverage the high resolution to see the unseen for more confident interpretations. Its unique quantitative1 capabilities may provide the ability to monitor and adjust treatments earlier by accurately measuring even small differences. To support patient safety and increased efficiency, Symbia Intevo was designed to administer the lowest2 dose while imaging patients faster than ever.

Biograph mCT Flow

Powered by Siemens’ revolutionary FlowMotion™ technology, Biograph mCT Flow™3 is the world’s first PET•CT system to eliminate the demand for stop-and-go imaging. With Biograph mCT Flow and FlowMotion, planning and scanning is based on a single continuous motion of the patient table.

The Baton Pass

Siemens has joined forces with Stand Up To Cancer® for The Baton Pass™—campaign to support SU2C's innovative, accelerated cancer research, which focuses on getting new therapies to patients quickly and saving lives now.

The Baton symbolizes the courage embodied in everyone touched by cancer, and the hope that one day, every cancer patient will become a cancer survivor. This hope is passed from person to person each time the Baton changes hands.

For every pass of the Baton - either physically or virtually through - from March 19, 2014 through September 5, 2014, Siemens will donate $1 to Stand Up To Cancer—up to one million dollars. While at SNMMI, you are invited to stop by Siemens booth and pass The Baton.

Siemens supplies the healthcare industry with imaging and diagnostic technology, and shares SU2C’s goal of advancing cancer research. We have seen firsthand the power of an early and accurate diagnosis. Our diagnostic technologies have made it possible to detect cancer in some of its earliest stages.

Learn more about Siemens’ efforts in the fight against cancer and how you can get involved by visiting The Baton Pass on Facebook.

The Baton Pass

Scientific Talk Schedule

Below is a selection of educational and scientific talks from the official SNMMI program that will be taking place at the St. Louis Convention Center.


Saturday, June 7th Rm# 228
Molecular Imaging and Targeted Therapeutics

11:15 am -12:00 pm
Amyloid PET Imaging in Clinical Trials
Michael D. Devous, Sr., PhD


Saturday, June 7th Rm# 223-224
The Journey to PET/MRI: Present State and Future Applications

9:40 am -10:10 am
PET/MRI Quantitative Techniques
Georges N. El Fakhri, PhD

10:10 am -10:20 am Break

10:20 am -10:50 am
PET/MRI Applications in Neurodegenerative Disorders
Alexander E. Drzezga, MD

12:50 pm -1:20 pm
PET/MRI Applications in Imaging Gynecological Malignancies
Farrokh Dehdashti, MD


1:20 pm -1:45 pm
PET/MRI Applications in Imaging in Multiple Myeloma
Lale Kostakoglu, MD, MPH


Saturday, June 7th Rm# 226
Advances in Clinical and Molecular Nuclear Cardiology

10:35 am - 11:10 am
Evaluation of Right Ventricular Function and Its Prognostic Relevance
Daniel S. Berman, MD


11:10 am - 11:45 am
Hybrid SPECT/CT, PET/CT, and PET/MR for CAD Detection
Thomas Hellmut Schindler, MD

12:45 pm - 1:15 pm
Imaging Vascular Inflammation and Atherosclerosis
Mehran M. Sadeghi, MD


1:15 pm - 1:45 pm
NaF for Imaging Coronary Artery and Valvular Calcification
Albert J. Sinusas, MD,FACC, FAHA


Saturday, June 7th Rm# 220-221
Theranostics Nuclear Medicine in Oncology – Updates and Future Directions

1:45 pm - 2:10 pm
Updates on Peptide Receptor Radionuclide Therapy
Richard P. Baum, MD, PhD

Saturday, June 7th Rm# 229
Molecular Imaging for Assessing Response to Therapy

3:00 pm - 4:00 pm
Novel Molecular Imaging Agents for Monitoring Response to Therapy
David A. Mankoff, MD, PhD


Saturday, June 7th Rm# 274
The Most Used PET Radiotracers Beyond F-18 FDG in Korea

4:30 pm - 5:00 pm
The Clinical Value of High-Resolution PET/CT Using F-18 FP-CIT for the Differential Diagnosis of Atypical Parkinsonian Disorders
Jae Seung Kim, MD, PhD


Saturday, June 7th Rm# 267
Pediatric Hybrid Imaging

5:00 pm - 5:30 pm
SPECT/CT in Pediatric Oncology
Helen R. Nadel, MD


Sunday, June 8th Rm# 220-221
PET Imaging of Hypoxia and Radiation Therapy *

1:20 pm - 1:45 pm
Hypoxia PET/CT Clinical Studies and Radiation Therapy
Farrokh Dehdashti, MD


Sunday, June 8th Rm# 220-221
Practical PET

3:15 pm - 3:45 pm
How to Perform, Interpret, and Report PET Myocardial Perfusion Imaging
Parthiban Arumugam, MD


Sunday, June 8th Rm# 267
Imaging Proteinopathies in Neurodegenerative Diseases

2:45 pm - 3:15 pm
Amyloid PET Tracers
Alexander E. Drzezga, MD


Sunday, June 8th Rm# 240
Amyloid and Tau PET Imaging: Current Status

5:00 pm - 5:30 pm
The Centiloid Project
Christopher C. Rowe, MD, FRACP


5:30 pm - 6:00 pm
Advances in Tau PET
Nobuyuki Okamura, MD, PhD


Sunday, June 8th Rm# 267
Differentiating Benign from Malignant Bone Disease: The Role of Multimodality Imaging

4:30 pm - 5:00 pm
Differentiating Benign from Malignant Bone Disease: The Role of PET/CT
Andrei Horia Iagaru, MD, FACNM

5:00 pm - 5:30 pm
Differentiating Benign from Malignant Bone Disease: The Role of SPECT/CT
Stephen C. Scharf, MD


Sunday, June 8th Rm# 222
PET/CT and PET/MR Imaging of Atherosclerosis and Vulnerable Plaque

5:00 pm - 5:30 pm
PET/CT in Clinical Trials of Atherosclerosis
Ahmed Tawakol, MD


Monday, June 9th Rm# 220-221
Quantitative PET for Therapy Planning and Assessment of Response *

12:30 pm - 1:15 pm
Advances and Technical Challenges Toward Quantitatively Harmonized PET Imaging for Cancer Clinical Trials and Clinical Practice
John J. Sunderland, PhD


1:15 pm - 2:00 pm
Clinical Applications of Quantitative Imaging in Planning and Assessing Cancer Therapies
Richard L. Wahl, MD


Monday, June 9th Rm# 222
SPECT/CT and PET/CT Respiratory Gating

1:15 pm - 2:00 pm
Do We Need Respiratory Gating for PET/CT Imaging?
Tinsu Pan, PhD


Monday, June 9th Rm# 241-242
Multimodality Imaging of Neuroendocrine Malignancies and Synergy with Therapy

1:00 pm - 1:30 pm
SPECT/CT and PET/CT with Various Molecular Imaging Agents in Neuroendocrine Tumors
Richard P. Baum, MD, PhD

Monday, June 9th Rm# 222
PET and Multiparametric MRI of Prostate Cancer

4:45 pm - 5:30 pm Multiparametric MRI of Prostate Cancer
Drew A. Torigian, MD, MA

5:30 pm - 6:15 pm Translational and Clinical PET of Prostate Cancer
Hossein Jadvar, MD,PhD,MPH,MBA,FACNM


Tuesday, June 10th Rm# 241-242
Liver-Directed Therapy with Y-90 Microspheres

8:30 am - 9:00 am
The Role of PET/CT in Y-90 Microsphere Quantification and Dosimetry
Vanessa L. Gates, MS

9:00 am - 9:30 am
Radiation Dosimetry and Outcomes in Y-90 Microsphere Therapy
Shyam M. Srinivas, MD, PhD

Tuesday, June 10th Rm# 223-224
Brain Analysis Software in PET/CT and SPECT/CT *

10:00 am - 10:45 am
Diagnostic Statistical Brain Mapping Analysis for Brain PET Analysis in Dementia
Satoshi Minoshima, MD, PhD


Tuesday, June 10th Rm# 274
Advances in PET Myocardial Perfusion Imaging: Radiotracers and Quantification of Blood Flow

10:00 am - 10:15 am Regulation of Myocardial Perfusion and Flow: Role of the Epicardial and Microcirculation
Heinrich R. Schelbert, MD, PhD


10:15 am - 10:30 am
Tracers for Perfusion and Flow – Can Rb82 Do the Job of NH3 and H20, and What About Flurpiridaz?
Jamshid Maddahi, MD


11:00 AM - 11:15 AM Clinical Value of Flow Quantification to Guide Therapy
Viviany R. Taqueti, MD, MPH


Tuesday, June 10th Rm# 223-224
Clinical Dosimetry of I-131 and Y-90 Therapies for Thyroid and Hepatic Malignancies *

12:30 PM - 1:15 PM Yttrium-90 Microsphere Therapy Planning and Dose Calculations
Srinivas Cheenu Kappadath, PhD


Tuesday, June 10th Rm# 223-224
SPECT/CT in Thyroid and Parathyroid Disease

2:45 pm - 3:30 pm
Thyroid Cancer Imaging:The Role of Diagnostic Radioiodine SPECT/CT
Anca M. Avram, MD


Wednesday, June 11th Rm# 240
Potentials of Brain PET/MRI

8:00 AM - 8:30 AM The Technical Revolution of Integrated PET/MRI
Bernd J. Pichler, PhD


8:30 am - 9:00 am
Methodological Challenges and Opportunities in Brain PET/MRI
Ciprian Catana, MD, PhD


9:00 am - 9:30 am
Future Applications for Brain PET/MRI
Osama Sabri, MD, PhD


Wednesday, June 11th Rm# 274

9:45 am - 10:15 am
Technical Developments in PET/MRI
Craig S. Levin, PhD

10:15 am - 10:45 am
Clinical Aspects of PET/MRI
Alexander R. Guimaraes, MD, PhD



Customer Service

A new dimension in remote technology

Are you interested in the latest innovations in remote customer care? Siemens certified application specialists deliver personalized application support in real time and via our secured remote connection called Siemens Remote Service (SRS).

Siemens Customer Service is there whenever you need us. Simply call your local Siemens Customer Care Center, select secure remote desktop sharing and interact with your Siemens certified Healthcare professional in real time.

Siemens Healthcare is among the first to implement an international information security management system enabling us to provide remote service for our customers.
Benefit from fast, expert solutions tailored to your needs via remote interactive application support and training:

• Real-time virtual application support
• Fewer workflow interruptions thanks to immediate solutions
• Higher level of efficiency and productivity
• Increased patient throughput
• Remote, seamless and interactive training at your workplace
• Easy and cost-efficient application training of new staff

Siemens Customer Services: there wherever and whenever you need us-visit us at SNMMI 2014 to learn more about our latest innovations in customer care.


Customer service

Peer to Peer Sessions

Peer to Peer (#P2P) Sessions

At SNMMI 20104, you have the opportunity to chat peer to peer (#P2P) with invited Siemens customers, including clinical experts using Biograph mCT Flow™1 and Symbia Intevo™1
in daily clinical routine and obtain feedback on their experiences and results to date.

Dedicated #P2P Session

Innovation Guest Sunday, June 8th Monday, June 9th

Biograph mCT
Dustin Osborne, M.S. Physics 10:00 a.m-11:00 a.m.
Flow University of Tennessee
Shelley Acuff, N.M.T.
University of Tennessee

Symbia Intevo
Dale Bailey, PhD 11:15 a.m-12:15 p.m.
Royal North Shore Hospital

Symbia Intevo Dr. Zsolt Szabo MD, PhD 11:30 a.m.-12:30 p.m. The John Hopkins Hospital

Biograph mCT
Shelley AcuffN.M.T.2:00 p.m.-3:00 p.m.
University of Tennessee

If you are interested in any of these sessions, please visit the Siemens reception desk at booth #821 and request your dedicated regional Siemens representative or, alternatively, request Kat Swystun to arrange an appointment.

You can find further information at our website

A glimpse at our invited peers for the #P2P sessions

Biograph mCT Flow
Dustin Osborne, M.S. Physics
Director, Clinical Research: Molecular Imaging and Translational Research Program at the University of Tennessee, Tennessee, USA. In addition, he is an Assistant Professor in Radiology and Institute for Biomedical Engineering as well as Medical Imaging Program Coordinator for the same institute, for the University of Tennessee.

Dustin has extensive prior experience within Siemens Medical Solutions specifically in preclinical imaging and research. As the Director of Clinical Research, Dustin is actively involved in the collaborative efforts of Biograph mCT Flow and FlowMotion technology and is an advocate of the technology.

Shelley Acuff, RT., N.M.T.
Clinical Research Leader of Molecular Imaging and Translational Research Program at the University of Tennessee, Tennessee, USA, overseeing all research imaging utilizing PET/CT imaging. Shelley’s expertise derives from almost 10 years of hands on clinical experience both in radiology and nuclear medicine, including hands on experience with FlowMotion technology, utilization and protocol design. Shelley’s hands on experience provides an inside look at how FlowMotion technology benefits day-to-day clinical routine.

As the Clinical Research Leader for PET/CT, Shelley is actively involved in the collaborative efforts of Biograph mCT Flow and FlowMotion technology and is an advocate of the technology.

Symbia Intevo

Zsolt Szabo M.D., PH.D.
Professor of Radiology at The John Hopkins Medical Institutions, Russell H. Morgan Department of Radiology and Radiological Science, Maryland, USA. Dr. Szabo has over 30 years experience in the field of Nuclear Medicine, and is a very active participant including a recent lecture in “Quantitative SPECT/CT. Nuclear Molecular Imaging and Therapy: Focus on Value.” (March 7-8, 2014) for The John Hopkins University School of Medicine as part of the Continuing Medical Education program for physicians.

Dr. Szabo is a key collaborator for xSPECT technology, including xSPECT Bone and xSPECT Quant. As part of the collaboration he is a key author of “Evaluation of image quality and clinical acceptance of xSPECT Bone, a novel multi modal SPECT/CT reconstruction method for Tc99m diphosphonate imaging.” (June 2014) which concluded that the visual evaluation of 10 readers, showed that xSPECT Bone improved image resolution, noise, diagnostic utility and image acceptance in clinical practice.

Dale Bailey, Ph.D.

The principle physicist at the Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia. In addition, he is a Professor for the School of Medical Radiation Sciences and Clinical Professor for the Sydney Medical School, at the University of Sydney.

Dale Bailey, has over 30 years experience in the field and is a very active participant in nuclear medicine both in SPECT and PET, his accomplishments include publications such as “Physics and Technology of SPECT/CT. Clinical Applications of SPECT-CT” (2014) and “Quantitative SPECT/CT: SPECT joins PET as a quantitative imaging modality”, (EJMMI Aug 2013), where he promotes Siemens Symbia Intevo as the first commercially available quantitative SPECT system.